TY - JOUR
T1 - Номенклатура функции и болезней почек
T2 - отчет о результатах согласительной конференции инициативы по улучшению глобальных исходов заболеваний почек (KDIGO)
AU - Levey, Andrew S.
AU - Eckardt, Kai Uwe
AU - Dorman, Nijsje M.
AU - Christiansen, Stacy L.
AU - Hoorn, Ewout J.
AU - Ingelfinger, Julie R.
AU - Inker, Lesley A.
AU - Levin, Adeera
AU - Mehrotra, Rajnish
AU - Palevsky, Paul M.
AU - Perazella, Mark A.
AU - Tong, Allison
AU - Allison, Susan J.
AU - Bockenhauer, Detlef
AU - Briggs, Josephine P.
AU - Bromberg, Jonathan S.
AU - Davenport, Andrew
AU - Feldman, Harold I.
AU - Fouque, Denis
AU - Gansevoort, Ron T.
AU - Gill, John S.
AU - Greene, Eddie L.
AU - Hemmelgarn, Brenda R.
AU - Kretzler, Matthias
AU - Lambie, Mark
AU - Lane, Pascale H.
AU - Laycock, Joseph
AU - Leventhal, Shari E.
AU - Mittelman, Michael
AU - Morrissey, Patricia
AU - Ostermann, Marlies
AU - Rees, Lesley
AU - Ronco, Pierre
AU - Schaefer, Franz
AU - St. Clair Russell, Jennifer
AU - Vinck, Caroline
AU - Walsh, Stephen B.
AU - Weiner, Daniel E.
AU - Cheung, Michael
AU - Jadoul, Michel
AU - Winkelmayer, Wolfgang C.
N1 - Publisher Copyright:
Copyright © 2020, International Society of Nephrology.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - The worldwide burden of kidney disease is rising, but public awareness remains limited, underscoring the need for more effective communication by stakeholders in the kidney health community. Despite this need for clarity, the nomenclature for describing kidney function and disease lacks uniformity. In June 2019, Kidney Disease: Improving Global Outcomes (KDIGO) convened a Consensus Conference with the goal of standardizing and refining the nomenclature used in the English language to describe kidney function and disease, and of developing a glossary that could be used in scientific publications. Guiding principles of the conference were that the revised nomenclature should be patient-centered, precise, and consistent with nomenclature used in the KDIGO guidelines. Conference attendees reached general consensus on the following recommendations: (i) to use “kidney” rather than “renal” or “nephro-” when referring to kidney disease and kidney function; (ii) to use “kidney failure” with appropriate descriptions of presence or absence of symptoms, signs, and treatment, rather than “end-stage kidney disease”; (iii) to use the KDIGO definition and classification of acute kidney diseases and disorders (AKD) and acute kidney injury (AKI), rather than alternative descriptions, to define and classify severity of AKD and AKI; (iv) to use the KDIGO definition and classification of chronic kidney disease (CKD) rather than alternative descriptions to define and classify severity of CKD; and (v) to use specific kidney measures, such as albuminuria or decreased glomerular filtration rate (GFR), rather than “abnormal” or “reduced” kidney function to describe alterations in kidney structure and function. A proposed 5-part glossary contains specific items for which there was general agreement. Conference attendees acknowledged limitations of the recommendations and glossary, but they considered standardization of scientific nomenclature to be essential for improving communication.
AB - The worldwide burden of kidney disease is rising, but public awareness remains limited, underscoring the need for more effective communication by stakeholders in the kidney health community. Despite this need for clarity, the nomenclature for describing kidney function and disease lacks uniformity. In June 2019, Kidney Disease: Improving Global Outcomes (KDIGO) convened a Consensus Conference with the goal of standardizing and refining the nomenclature used in the English language to describe kidney function and disease, and of developing a glossary that could be used in scientific publications. Guiding principles of the conference were that the revised nomenclature should be patient-centered, precise, and consistent with nomenclature used in the KDIGO guidelines. Conference attendees reached general consensus on the following recommendations: (i) to use “kidney” rather than “renal” or “nephro-” when referring to kidney disease and kidney function; (ii) to use “kidney failure” with appropriate descriptions of presence or absence of symptoms, signs, and treatment, rather than “end-stage kidney disease”; (iii) to use the KDIGO definition and classification of acute kidney diseases and disorders (AKD) and acute kidney injury (AKI), rather than alternative descriptions, to define and classify severity of AKD and AKI; (iv) to use the KDIGO definition and classification of chronic kidney disease (CKD) rather than alternative descriptions to define and classify severity of CKD; and (v) to use specific kidney measures, such as albuminuria or decreased glomerular filtration rate (GFR), rather than “abnormal” or “reduced” kidney function to describe alterations in kidney structure and function. A proposed 5-part glossary contains specific items for which there was general agreement. Conference attendees acknowledged limitations of the recommendations and glossary, but they considered standardization of scientific nomenclature to be essential for improving communication.
UR - http://www.scopus.com/inward/record.url?scp=85093502994&partnerID=8YFLogxK
UR - https://www.sciencedirect.com/science/article/pii/S0085253820302337?via%3Dihub#!
U2 - 10.28996/2618-9801-2020-3-271-292
DO - 10.28996/2618-9801-2020-3-271-292
M3 - Article
AN - SCOPUS:85093502994
SN - 1680-4422
VL - 22
SP - 271
EP - 292
JO - Nephrology and Dialysis
JF - Nephrology and Dialysis
IS - 3
ER -